0505825 - MBÚ 2020 RIV CH eng J - Journal Article
Funda, David P. - Palová-Jelinková, L. - Goliáš, Jaroslav - Kroulíková, Zuzana - Fajstová, Alena - Hudcovic, Tomáš - Spíšek, R.
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
Frontiers in Immunology. Roč. 10, MAY 14 (2019), č. článku 967. ISSN 1664-3224. E-ISSN 1664-3224
R&D Projects: GA MZd(CZ) NV16-27994A
Institutional support: RVO:61388971
Keywords : type 1 diabetes * cell therapy * animal models
OECD category: Microbiology
Impact factor: 5.085, year: 2019
Method of publishing: Open access
https://www.frontiersin.org/articles/10.3389/fimmu.2019.00967/full
Permanent Link: http://hdl.handle.net/11104/0297201
Funda, David P. - Palová-Jelinková, L. - Goliáš, Jaroslav - Kroulíková, Zuzana - Fajstová, Alena - Hudcovic, Tomáš - Spíšek, R.
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
Frontiers in Immunology. Roč. 10, MAY 14 (2019), č. článku 967. ISSN 1664-3224. E-ISSN 1664-3224
R&D Projects: GA MZd(CZ) NV16-27994A
Institutional support: RVO:61388971
Keywords : type 1 diabetes * cell therapy * animal models
OECD category: Microbiology
Impact factor: 5.085, year: 2019
Method of publishing: Open access
https://www.frontiersin.org/articles/10.3389/fimmu.2019.00967/full
Permanent Link: http://hdl.handle.net/11104/0297201